Finance

Lists
3349:TYO
Cosmos Pharmaceutical Corp
JP¥ ६,३१४.००
-०.२२%
(-१४.००) 1D
अक्टोबर ६, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3349...
Open
JP¥ ६,३०३
High
JP¥ ६,३३९
Low
JP¥ ६,२५८
Mkt. cap
५.०५ खरब
Avg. vol.
४.३६ लाख
Volume
३.६३ लाख
Dividend
१.३०%
Quarterly dividend
JP¥ २१
Ex-dividend date
२०२६ नोभेम्बर २७
P/E ratio
१५.६२
52-wk high
JP¥ ८,५९०
52-wk low
JP¥ ५,६१५
EPS
JP¥ ४०४
Shares outstanding
१.९८ करोड
No. of employees
६ हजार
Open
JP¥ ६,३०३
High
JP¥ ६,३३९
Low
JP¥ ६,२५८
Mkt. cap
५.०५ खरब
Avg. vol.
४.३६ लाख
Volume
३.६३ लाख
Dividend
१.३०%
Quarterly dividend
JP¥ २१
Ex-dividend date
२०२६ नोभेम्बर २७
P/E ratio
१५.६२
52-wk high
JP¥ ८,५९०
52-wk low
JP¥ ५,६१५
EPS
JP¥ ४०४
Shares outstanding
१.९८ करोड
No. of employees
६ हजार
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
२० मिनेट पहिले
What Does Ascendis Pharma (ASND) Gain From Its CNP Patent Settlement?
Bloomberg.com
Bloomberg.com
·
४२ मिनेट पहिले
Record Run for US Stocks to Set Tone for Asia: Markets Wrap
Investor's Business Daily
Investor's Business Daily
·
२ घण्टा पहिले
Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead 6 AI Stock Buys
About Cosmos Pharmaceutical Corp
CEO-
Employees५.९८ हजार
Foundedडिसेम्बर १९८३
Headquarters-
Sector-
Next call ६ दिनमा
अक्टोबर १३, मङ्गल, ००:००
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
- / २.९१ खरब
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ अगस्ट
२०२५ नोभेम्बर
२०२६ फेब्रुअरी
२०२६ मे
Revenue
२.७२ खरब
२.६५ खरब
२.७३ खरब
२.८९ खरब
Cost of goods sold
२.१५ खरब
२.०९ खरब
२.१६ खरब
२.२९ खरब
Cost of revenue
२.१५ खरब
२.०९ खरब
२.१६ खरब
२.२९ खरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४५.६४ अरब
४६.५७ अरब
४५.८३ अरब
२६.४३ अरब
Operating expense
४५.६४ अरब
४६.५७ अरब
४५.८३ अरब
४९.०८ अरब
Total operating expenses
२.६१ खरब
२.५६ खरब
२.६२ खरब
२.७९ खरब
Operating income
११.५४ अरब
९.१४ अरब
११.२३ अरब
१०.६६ अरब
Other non operating income
६२.७० करोड
८०.१० करोड
६६.७० करोड
६९.५० करोड
EBT including unusual items
१२.०९ अरब
९.५८ अरब
११.९६ अरब
१०.६० अरब
EBT excluding unusual items
१२.०८ अरब
९.८५ अरब
११.८१ अरब
११.१२ अरब
Income tax expense
३.९२ अरब
३.१० अरब
३.८६ अरब
१.३० अरब
Effective tax rate
३२.४०%
३२.३५%
३२.२६%
१२.२६%
Other operating expenses
-
-
-
-
Net income
८.१७ अरब
६.४८ अरब
८.१० अरब
९.३० अरब
Net profit margin
३.००%
२.४५%
२.९६%
३.२१%
Earnings per share
-
-
-
-
Interest and investment income
२.७० करोड
१.९० करोड
१.६० करोड
१.२० करोड
Interest expense
-११.०० करोड
-१०.७० करोड
-१०.७० करोड
-२५.७० करोड
Net interest expenses
-८.३० करोड
-८.८० करोड
-९.१० करोड
-२४.५० करोड
Depreciation and amortization charges
-
-
-
२२.६४ अरब
EBITDA
१७.०९ अरब
१५.०० अरब
१६.७९ अरब
१६.८१ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू